Clinical trial
Metformin as Adjuvant Therapy in Obese Knee Osteoarthritis Patients
NCT05638893 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metformin as Adjuvant Therapy in Obese Knee Osteoarthritis Patients
- Lead sponsor
- Tanta University
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- February 1, 2021
- Completion date
- April 15, 2022
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
knee osteoarthritis